INTRODUCTION
Drug poisoning has been defined as a condition produced by any substance which when swallowed, inhaled, injected or absorbed percutaneously is capable of causing death, injury, toxic or untoward reactions 1 . Poisoning is a very common clinical problem and could occur with the fluoroquinolones. The major principles applied in the emergency treatment of accidental poisoning by drugs are dilution, emesis and adsorption 2 .
In cases where no specific antidotes exist, prevention of further absorption of a drug from the oral route is by use of oral adsorbents. This could be of immense benefit in the management of drug over dose and/or poisoning. The use of standard adsorbents such as activated charcoal in the prevention of further absorption of drugs, is recognised in clinical practice 3 . The safety of activated charcoal is remarkable because it is non reactive and non absorbable from the gastro-intestinal tract 4 .
The fluoroquinolones are a new series of synthetic antimicrobial agents that have a broad spectrum of activity against both gram-positive and gram-negative organisms 5, 6 .
They are available and active as oral dosage forms. They are well absorbed from the oral route and distribute well into body fluids and tissues to attain effective inhibitory concentrations [7] [8] [9] . Though they are well tolerated, a few adverse effects which include gastrointestinal effects, disturbances of the CNS, phototoxic reactions, liver enzyme abnormalities, arthropathy, tendinitis and tendon rupture and prolongation of QT c interval have been reported [10] [11] [12] [13] . Though no reports are available on accidental or deliberate poisoning with the fluoroquinolones, their extensive use warrants investigation into possible effective antidotes in cases of accidental poisoning or overdose especially in elderly patients, in patients with renal impairment, and in children in whom these fluoroquinolones are contra-indicated as a result of drug-induced arthropathy. We present in this report our investigations into the in-vitro adsorption of the fluoroquinolones exemplified by ciprofloxacin, ofloxacin and norfloxacin (the most commonly prescribed and available fluoroquinolones) on some commercially available pharmaceutical adsorbents -activated charcoal, kaolin and bentonite. The aim is to provide baseline data that would characterise the rate and extent of adsorption of the fluoroquinolones on these adsorbents which could guide the pharmacist and other healthcare givers in the choice of antidotes in the event of overdosage and/or poisoning with the fluoroquinolones.
EXPERIMENTAL Materials
Ofloxacin powder was kindly supplied by Hoechst Germany, through Nigeria -German Chemicals, Nigeria.
Pure powders of ciprofloxacin hydrochloride and norfloxacin were supplied by Sam Pharmaceuticals, Nigeria. Adsorbents used included activated charcoal and light kaolin from BDH Chemicals, UK, while bentonite was from Halewood Chemicals Ltd, UK. Hydrochloric acid was from Sigma -Aldrich Laboratory, Germany. Equipment: Ultrospec 3000 ultra-violet/visible spectrophotometer from Pharmacia Biotech, UK was used to take all the absorbance readings. Thermo-statted shaker bath from Gallenkamp, UK set at 37± 0.2°C was used to shake fluoroquinolone -adsorbent mixtures and B α T hot air oven from Bird and Tat lock UK was used to dry the adsorbents. The adsorbents were activated by drying at 110°C for five hours in the oven for activated charcoal and for three hours for kaolin and bentonite. They were then cooled and stored in the descicator. Two types of experiments were carried out. The first was to investigate the time to attain equilibrium while the second was to find out the extent of adsorption of each of the fluoroquinolones on the adsorbents. For the time to reach equilibrium study, 15ml of standard solutions of each fluoroquinolone in 0.1M hydrochloric acid were added separately into 25ml volumetric flasks to which graded amounts of each adsorbent were put. Similarly, 15ml of 0.1M hydrochloric acid was added to equal graded amounts of adsorbent in 25ml volumetric flasks. The slurries were mixed and put in the shaker bath set at 80 oscillations per minute and at 37 ± 0.2°C. Aliquots of the mixtures were withdrawn at separate time intervals and centrifuged at 3000g for five minutes. Portions of the clear supernatant was diluted serially and the absorbance of the final solution measured at the λ max for the respective drug. The slurries with 15ml 0.1M hydrochloric acid (without fluoroquinolone) treated in a similar way served as blanks for the absorbance measurements. From the Beer's plot for the fluoroquinolone previously made, the amount of free drug in solution was determined. From the results, the time to attain equilibrium for each adsorbent was determined. The procedure was repeated for each pair of fluoroquinolone and adsorbent.
Methods

Standard
For the adsorption equilibrium studies, 15ml of standard solution of fluoroquinolone was added to graded amounts of adsorbent in separate 25ml volumetric flasks. Similarly, 15ml of 0.1M hydrochloric acid was added to equal graded amounts of adsorbent in 25ml volumetric flasks. The slurries were mixed and put in a shaker bath set at 80 oscillations per minute and at 37 ± 0.2°C. The shaking was continued for a period exceeding the time to attain equilibrium for the adsorbent. Thereafter, part of the mixture was taken and treated as above. Aliquot of the clean supernatant was diluted serially and the absorbance of the resultant fluoroquinolone solution measured at its λ max . The slurries with 15ml 0.1M hydrochloric acid (without fluoroquinolone) treated in a similar way served as blanks for the absorbance measurements. From the Beer's plot of the fluoroquinolone obtained earlier at the λ max , the amounts of free drug remaining in solution at equilibrium in the presence of graded amounts of the adsorbent were determined hence the amount adsorbed was calculated. The procedure was repeated for each fluoroquinolone -adsorbent pair.
RESULTS
In 0.1M hydrochloric acid, ciprofloxacin, ofloxacin and norfloxacin had λ max values of 277nm, 278nm and 274nm respectively. At each λ max , Beer's law was obeyed for each fluoroquinolone.
The study to know when equilibrium was attained showed that with activated charcoal as adsorbent, adsorption equilibrium was attained rapidly within 15 minutes with each of the fluoroquinolones. But with kaolin and bentonite, adsorption equilibrium was attained less rapidly but within two hours with each of the fluoroquinolones.
In the presence of graded amounts of each adsorbent, the equilibrium studies fitted into Langmuir's equation Table 1 . DISCUSSION 0.1M hydrochloric acid was used to mimic the acidity of the stomach where drugs that are taken orally are retained for some time prior to absorption from the gastro-intestinal tract. Shaking at 37°C was to mimic gastro-intestinal motility and body temperature. From the time to attain equilibrium studies, activated charcoal adsorbed the fluoroquinolones rapidly thus equilibrium was attained within 15 minutes. This is a desirable feature of an adsorbent antidote. The ability to adsorb any poison or excess drug rapidly in the case of overdose helps to prevent the poison or drug from being absorbed significantly and thus reduces fatality and mortality. Activated charcoal has been known to have this desirable property, hence it has been used generally as an antidote [15] [16] [17] . On the other hand, kaolin and bentonite were slower to attain equilibrium with the fluoroquinolones. It took The binding constants of bentonite for the fluoroquinolones were also high and of the same order of magnitude as those of activated charcoal. Thus, it can be an effective antidote for fluoroquinolone overdose. Bentonite has been shown to have a stronger adsorption capacity for aromatic hydrocarbons than kaolin 19 . Though both bentonite and activated charcoal had similar binding constants, the rate of adsorption on bentonite was slower and thus activated charcoal would be preferred to bentonite. For all the fluoroquinolones, the binding constants for kaolin was very low. Thus, kaolin cannot effectively bind the fluoroquinolones and prevent them from being absorbed from the gastro-intestinal tract in the case of overdose or accidental poisoning. Kaolin cannot be an effective antidote for the fluoroquinolones.
The mechanism of adsorption of various drugs on activated charcoal has been extensively studied and known to proceed by surface phenomenon 20 . The high binding capacity of activated charcoal has been attributed to its high surface area. Similarly, kaolin is an adsorbent that is normally administered in the symptomatic treatment of enteritis, colitis and dysentery associated with food and alkaloidal poisoning. Adsorption of drugs on it is also purely a surface phenomenon. But for bentonite which swells in aqueous medium to form a gel, the mechanism of adsorption may be by entrapment of the fluoroquinolones by the gel rather than by surface adsorption. In the acidic medium used in this study, the fluoroquinolones existed in their cationic forms. Thus when adsorbed on the surface of the adsorbents they would repel each other and incoming cations electrostatically, hence they cannot pack densely onto the surface. This may be the reason why Langmuir's isotherm was followed as multi-layer adsorption of drugs may not be possible. Despite such limitations, activated charcoal still adsorbed the fluoroquinolones strongly and rapidly.
Kaolin and bentonite were chosen for this study because of their reported adsorptive properties with other drugs. They are also commonly used as drugs and in pharmaceutical formulations. They are safe. But more importantly, they were investigated as alternatives to activated charcoal which precipitates vomiting when large doses are given. From the results, it has become obvious that the adsorptive capacity and rate of adsorption of the fluoroquinolones onto activated charcoal were superior to kaolin. Also, the rate of adsorption onto activated charcoal made it a better antidote for the fluoroquinolones than bentonite. Moreover, the swelling observed with aqueous bentonite solutions will lead to serious constipation unless it is co-administered with a carthartic. Magnesium trisilicate -a known adsorbent was not investigated in this study because magnesium complexes with the fluoroquinolones and the effect due to this complexation will further complicate its adsorptive properties.
CONCLUSION
Activated charcoal strongly and rapidly adsorbed the fluoroquinolones in acid medium in-vitro. Thus, it could be effectively used to prevent fluoroquinolone absorption from the gastrointestinal tract in cases of overdose or poisoning. Activated charcoal was superior to both kaolin and bentonite as an adsorbent for the fluoroquinolones. Though bentonite had a high adsorbing capacity for the fluoroquinolones, it was slow in adsorbing them. Moreover, its swelling behaviour in aqueous medium makes it less attractive.
Kaolin adsorbed the fluoroquinolones poorly in acid medium. Activated charcoal can serve as a good antidote for fluoroquinolone overdose or poisoning. It should not therefore be administered concurrently with the fluoroquinolones in the treatment of infection as this would lead to therapeutic failure. On the other hand, kaolin can be concomitantly administered with the fluoroquinolones without adversely affecting the therapeutic efficacy of the fluoroquinolones.
